CAD 0.3
(-4.76%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | -2.2 Million CAD | -66.74% |
2022 | -1.31 Million CAD | 56.05% |
2021 | -3 Million CAD | -1165.37% |
2020 | -237.32 Thousand CAD | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q1 | -1.89 Million CAD | -161.14% |
2023 Q1 | -710.75 Thousand CAD | -70.27% |
2023 FY | -2.2 Million CAD | -66.74% |
2023 Q4 | -726.38 Thousand CAD | -111.68% |
2023 Q2 | -464.06 Thousand CAD | 34.71% |
2023 Q3 | -343.15 Thousand CAD | 26.06% |
2022 Q1 | -417.42 Thousand CAD | 59.88% |
2022 Q4 | -417.42 Thousand CAD | -101.08% |
2022 Q3 | -207.59 Thousand CAD | 26.59% |
2022 FY | -1.31 Million CAD | 56.05% |
2022 Q2 | -282.79 Thousand CAD | 32.25% |
2021 Q3 | -998.91 Thousand CAD | -143.74% |
2021 Q1 | -425.83 Thousand CAD | 0.0% |
2021 Q4 | -1.04 Million CAD | -4.15% |
2021 FY | -3 Million CAD | -1165.37% |
2021 Q2 | -409.82 Thousand CAD | 3.76% |
2020 FY | -237.32 Thousand CAD | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
AI/ML Innovations Inc. | -1.66 Million CAD | -32.179% |
Diagnamed Holdings Corp. | -1.17 Million CAD | -86.865% |
Pangenomic Health Inc. | -2.71 Million CAD | 18.849% |
nDatalyze Corp. | -316.56 Thousand CAD | -595.173% |
Treatment.Com International Inc. | -2.32 Million CAD | 5.427% |